Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 3 2

Status

Active not recruiting 3Recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1CNS 1Breast 1

Conditions

Rectal Neoplasms 1Meningioma 1Lymphoma, Mantle-Cell 1Genetic Diseases, Inborn 1Breast Neoplasms 1

Interventions

Specimen Handling 176Magnetic Resonance Spectroscopy 138Biopsy 102pembrolizumab 81Carboplatin 79Cisplatin 71Nivolumab 65Cyclophosphamide 64Paclitaxel 54Radiotherapy 48Gemcitabine 43durvalumab 39Doxorubicin 35Bevacizumab 34Fluorouracil 33venetoclax 32Dexamethasone 31Rituximab 30atezolizumab 29Radiation 29Capecitabine 28Lenalidomide 27Etoposide 27Prednisone 26Oxaliplatin 26Injections 26Pemetrexed 25Docetaxel 25olaparib 23fludarabine 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Tablets × 30 days × Clear all
NCT04503694 2026-05-22

REGINA

Jules Bordet Institute

Phase 2 Active not recruiting
72 enrolled
Gastrointestinal

Rectal Neoplasms

NCT05392608 2026-05-22

SEQUEL-Breast

Borstkanker Onderzoek Groep

Phase 2 Active not recruiting
130 enrolled
Breast

Breast Neoplasms, Genetic Diseases, Inborn

NCT04802590 2026-05-20

Study of Ibrutinib + CD20 Antibody and Venetoclax in Patients With Untreated Mantle Cell Lymphoma

The Lymphoma Academic Research Organisation

Phase 2 Active not recruiting
210 enrolled
Lymphoid

Lymphoma, Mantle-Cell

NCT06275919 2026-05-13

MIRAGE

Istituto Oncologico Veneto IRCCS

Phase 2 Recruiting
104 enrolled
CNS

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡